Metzger Michael A bought SNDX
July 8, 2026 · Form 4 insider transaction
Metzger Michael A bought 32,375 shares of Syndax Pharmaceuticals, Inc. at $6.38 per share, a transaction worth $206.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
32,375
Price
$6.38
Total value
$206.6K
InsiderMetzger Michael A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 8, 2026
Filing dateJuly 9, 2026
Shares owned after517,218
OwnershipDirect
10b5-1 planNo
AmendedNo